Literature DB >> 6837051

Systemic antibacterial mechanisms in trauma.

L D MacLean.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6837051     DOI： 10.1007/bf01655919

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  9 in total

1.  The effect of nitrogen-sparing, intravenously administered fluids on postoperative body composition.

Authors:  H M Shizgal; C A Milne; A H Spanier
Journal:  Surgery       Date:  1979-05       Impact factor: 3.982

2.  The value and duration of defence reactions of the skin to the primary lodgement of bacteria.

Authors:  A A MILES; E M MILES; J BURKE
Journal:  Br J Exp Pathol       Date:  1957-02

3.  A method of studying leukocytic functions in vivo.

Authors:  J W REBUCK; J H CROWLEY
Journal:  Ann N Y Acad Sci       Date:  1955-03-24       Impact factor: 5.691

4.  Dysfunction of humoral immunity in anergic surgical patients: absence of anti-tetanus IgG antibody production.

Authors:  R Mazaheri; H N Rode; K Abikar; A Ing; C Nohr; J Gordon
Journal:  J Clin Immunol       Date:  1984-01       Impact factor: 8.317

5.  Host defense in blunt trauma: interrelationships of kinetics of anergy and depressed neutrophil function, nutritional status, and sepsis.

Authors:  N V Christou; A P McLean; J L Meakins
Journal:  J Trauma       Date:  1980-10

6.  Postoperative depression of host resistance: determinants and effect of peripheral protein-sparing therapy.

Authors:  N V Christou; R Superina; M Broadhead; J L Meakins
Journal:  Surgery       Date:  1982-10       Impact factor: 3.982

7.  Humoral deficiency and reticuloendothelial depression after traumatic shock.

Authors:  J E Kaplan; T M Saba
Journal:  Am J Physiol       Date:  1976-01

8.  Immunological studies of anergic patients.

Authors:  D E Van Epps; J A Frierson; R C Williams
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

9.  Lymphocyte function in anergic patients.

Authors:  H N Rode; N V Christou; O Bubenik; R Superina; J Gordon; J L Meakins; L D MacLean
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.